The discovery in the present study that JorA increases Bid expression and decreases Bcl2, Bcl-XL, and Pax8 expression suggests that JorA accelerates the apoptosis of bladder cancer cells from multiple angles. Here, BCL2L1 is linked to urinary bladder cancer.